Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

186.97 +0.97 (+0.52%)
Official Closing Price Updated: 7:00 PM EST, Nov 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Global Market Jitters: US Downturn Triggers European Slump Amid AI and Economic Concerns
November 6, 2025 – Global financial markets today demonstrated their profound interconnectedness, as a significant downturn in US stocks rapidly transmitted a wave of apprehension across the Atlantic,... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Global Markets Brace for Impact: Economic Jitters Fuel Uncertainty Across US and Europe
Global financial markets are currently navigating a treacherous landscape of economic uncertainty, with a palpable sense of 'jitters' gripping investors across the United States and Europe. As of... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
US Stocks Tumble Amid AI Valuation Fears and Mounting Job Worries
The U.S. stock market experienced a notable downturn today, November 6, 2025, as investors grappled with growing apprehension over the lofty valuations of artificial intelligence (AI) stocks and a... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
US Stock Market Reels: Inflation Fears and Geopolitical Tensions Trigger Broad Retreat on November 6, 2025
Disclaimer: This article is based on a hypothetical market scenario for November 6, 2025, as real-time future market data is unavailable. The analysis draws upon common drivers of market retreats and... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Johnson & Johnson’s Newly Acquired Antipsychotic Drug Approved By FDA For Major Depressive Disorder
JNJ gained access to Caplyta with the $14.6 billion acquisition of Intra-Cellular Therapies, Inc., which closed in April. 
Via Stocktwits
Market Momentum Stalls: Valuations Under Scrutiny as Bullish Run Faces Headwinds
As November 2025 unfolds, the global stock markets find themselves at a critical juncture, struggling to reclaim the robust bullish momentum that characterized much of the preceding years. A palpable... 
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
S&P 500 Defies Gravity as Mass Layoffs Surge: A Paradoxical Market in November 2025
The U.S. economy is currently navigating a perplexing landscape, where a dramatic surge in mass layoffs, marking the highest October job cuts in 22 years, appears to be fueling, rather than hindering,... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
US Government Shutdown Casts a Shadow: Data Blackout and Market Jitters as Longest Shutdown Unfolds
The United States finds itself in an unprecedented economic fog as a prolonged government shutdown, now stretching well into its second month, has brought the flow of critical official data to a... 
Via MarketMinute
Topics Economy
Market Recovers from Tariff Turmoil: Dow, S&P 500, and Nasdaq Stage Resilient Rebound Amid Shifting Economic Winds
The U.S. financial markets have demonstrated remarkable resilience in 2025, staging a significant rebound after experiencing a sharp selloff earlier in the year. The Dow Jones Industrial Average, S&P... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns
Seattle, WA – November 5, 2025 – In a monumental leap for biotechnology and artificial intelligence, Nobel Laureate David Baker’s lab at the University of Washington’s Institute for Protein Design... 
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property
Vanguard Growth ETF vs. Vanguard Value ETF: Which ETF Will Outperform in 2026?
Growth stocks have outperformed in recent years, but will that continue? 
Via The Motley Fool
Topics ETFs
Navigating the Currents: A Prospective Look at November 4th, 2025 Market Movements
As the financial world turned its attention to November 4th, 2025, markets braced for a day shaped by a confluence of anticipated economic indicators and lingering geopolitical concerns. While specific... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
U.S. Government Shutdown Plunges Nation into Uncharted Economic Waters: Longest in History Deepens Market Uncertainty
Washington D.C., November 5, 2025 – The United States is grappling with an unprecedented fiscal crisis, as an ongoing government shutdown, now in its 36th day, has officially become the longest in the... 
Via MarketMinute
Topics Bonds Economy Government
The Shadow of Doubt: Why Investors Are 'Taking Fright' as Markets Brace for Reality
In the dynamic world of finance, where fortunes are made and lost in the blink of an eye, a chilling sentiment has begun to grip investors: the idea that stocks can, indeed, go down. This isn't merely... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Wall Street Titans Warn of Impending Stock Market Correction
New York, NY – November 4, 2025 – Major Wall Street institutions, Goldman Sachs (NYSE: GS) and Morgan Stanley (NYSE: MS), have issued fresh and urgent warnings regarding a potential significant stock... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Treasury Secretary Declares 'Housing Recession,' Pressures Fed for Immediate Rate Cuts
In a stark warning echoing through the financial markets, U.S. Treasury Secretary Scott Bessent declared this week that the American housing sector is already mired in a recession, directly attributing... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Options Corner: Kimberly-Clark's Implosion Offers An Unusual Informational Arbitrage Opportunity
Although Kimberly-Clark suffered a huge blow after announcing its Kenvue buyout, KMB stock is flashing a quantitative contrarian signal. 
Via Benzinga
Gold Edges Higher; ISM Manufacturing PMI Falls In October
 
Via Benzinga
Tech Titans Unite and Consumer Giants Merge: Amazon-OpenAI Partnership and Kenvue Buyout Ignite S&P 500 and Nasdaq Gains
November 3, 2025 – The U.S. stock markets are experiencing a significant surge today, with both the S&P 500 and Nasdaq Composite pushing towards new highs. This bullish sentiment is largely fueled by... 
Via MarketMinute
Topics Artificial Intelligence Lawsuit Stocks
Alvotech Shares Plunge 33% After FDA Flags Issues
Alvotech shares decline after the FDA issues a complete response letter for its Simponi biosimilar, leading to a lower 2025 revenue and EBITDA outlook. 
Via Benzinga
Kenvue's Megadeal Fuels Stock Market Rise at Week's Start: A New Consumer Health Giant Emerges
The financial markets have kicked off the week with a significant surge, largely propelled by the blockbuster acquisition of Kenvue Inc. (NYSE: KVUE) by Kimberly-Clark Corporation (NYSE: KMB). This... 
Via MarketMinute
Topics Supply Chain
Tech Titans and Consumer Giants Reshape Markets: Amazon's AI Leap and Kimberly-Clark's Mega-Merger
November 3, 2025, marks a pivotal day in the financial markets, witnessing two seismic corporate announcements that promise to redefine their respective industries. Amazon.com Inc. (NASDAQ: AMZN) has... 
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
Buffett Sells Stocks – Here Is What Prudent Investors Should Do Now; OPEC+ Changes Stance
Buffett Sells Stocks Please click here for a chart of Warren Buffett’s company Berkshire Hathaway Inc Class B (NYSE: 
Via Benzinga
Dow Jones Extends Gains as Palantir Eyes AI-Driven Surge and Kenvue Soars on Kimberly-Clark Takeover
New York, NY – November 3, 2025 – The Dow Jones Industrial Average is on track to extend its robust gains as the market closes out a strong trading day, buoyed by a confluence of positive factors... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Kimberly-Clark Stock Plunges Over 16%, Kenvue Surges 20% In Monday Pre-Market: What's Going On?
Shares of Kimberly-Clark Corporation (NASDAQ: KMB) plunged 16.49% during the pre-market trading session on Monday, after it announced the acquisition of Kenvue Inc. (NYSE: KVUE). 
Via Benzinga
Will President Trump's Tylenol Claims Hurt These 2 Leading Pharmaceutical Stocks?
Even though Kenvue's stock was already in a tailspin before the FDA warned pregnant woman that Tylenol posed a health risk, there are still some lingering impacts to consider. 
Via The Motley Fool
Topics Government
Johnson & Johnson Stock: Is Wall Street Bullish or Bearish?
Johnson & Johnson has delivered a standout performance in 2025, outperforming both the broader market and the healthcare sector. Analysts continue to be fairly bullish on the stock’s trajectory. 
Via Barchart.com
Amgen Solidifies Biotech Dividend Prowess with $2.38 Q4 2025 Payout
Thousand Oaks, CA – October 31, 2025 – Amgen (NASDAQ: AMGN), a leading biotechnology giant, has declared a quarterly dividend of $2.38 per share for the fourth quarter of 2025. This significant... 
Via MarketMinute
Topics Intellectual Property
AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs
San Francisco, CA – October 31, 2025 – Artificial intelligence (AI) is ushering in a transformative era for the pharmaceutical industry, particularly in the often-overlooked yet critical domain of... 
Via TokenRing AI
Topics Artificial Intelligence Supply Chain
AI Revolutionizes Pharma R&D: A New Era of Accelerated Drug Discovery and Personalized Medicine
Artificial intelligence (AI) is ushering in a transformative era for pharmaceutical research and development (R&D), fundamentally reshaping how new medicines are discovered, developed, and brought to... 
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.